This is often an update to the former recall that happened in March that failed to pose adverse health or safety dangers to the public. This recall is remaining categorised from the FDA as Class III, which is for solutions that violate federal polices but are unlikely to cause adverse health effects. The National Institutes of Health (NIH) notes